Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D2.03 - A Rare Case of Thyme Allergy in a Pediatric Patient: First Report and Clinical Insights
D2.04 - Sensitization to common food allergens in a population of portuguese children
D2.05 - A Retrospective Study Characterising the Types of Presentation of Soy Allergy in Adults
D2.06 - Peanut allergy diagnosis. Our experience
D2.08 - Post-Traumatic Stress Disorder Associated with Anaphylaxis
D2.09 - Correlation Patterns Among House Dust Mite Allergens in Allergic Rhinitis: A Molecular Sensitization Study in Mallorca
D2.10 - Can specific IgE components for egg allergy - predict egg ladder success?
D2.11 - A confidence score for basophil activation test: improving interpretation around diagnostic cutoffs
D2.12 - Indirect Basophil Activation Test: development of a user-friendly protocol for plasma and allergen testing
D2.13 - Structural Homology of Alt a 1 and Phl p 2 Suggests an explanation for coincidence of Grass and Alternaria Allergies
D2.15 - The etiology and risk factors of food allergies in children in Albania
D2.16 - Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen
D2.167 - Effect of Metformin on allergen specific immunotherapy
D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children
D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT
D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study
D2.168 - Systemic reactions to subcutaneous immunotherapy in children
D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season
D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment
D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download